TCR2 Therapeutics: Falls on $125 mln share offering

TCR2 Therapeutics

19/01/2021 15:04

** Biotech co's shares  TCRR.O  down 2.86% at $21.86
    ** Co announces public offering of $125 mln worth of common
stock  urn:newsml:reuters.com:*:nGNX8RY7LT
    ** Co intends to use net proceeds to advance clinical and
earlier stage programs, R&D, working capital and general
corporate purposes
    ** TCRR has a pipeline of novel T cell therapies for
patients suffering from cancer 
    ** Goldman Sachs & Co LLC, Jefferies, Piper Sandler and BMO
Capital Markets are acting as joint book-running managers for
the offering  

 (Reporting by Lasya Priya M in Bengaluru)
 ((LasyaPriya.M@thomsonreuters.com;))